Search
for
Sort by
Research 781–810 of 1000+
- Aqueous Extract of Bacopa procumbens and the NAPEL Formulation Mitigate MPTP-Induced Neurotoxicity via Nrf2/HSF1/HIF-1α Signaling in a Parkinson’s Disease Model
- Evaluating the hair regenerative potential of plant-based hair serum formulation: a comparative study
- Assessment of the efficacy and tolerability of a topical formulation containing caffeine and Procapil 3% for improvement of male pattern hair loss
- Therapeutic Approach for Hair Growth and Regeneration Using Bioactive Formulation Containing Mesenchymal Stromal Cell-Derived Conditioned Medium
- Response to Keith <i>et al.</i> Re: “Annurca Apple Nutraceutical Formulation Enhances Keratin Expression in a Human Model of Skin and Promotes Hair Growth and Tropism in a Randomized Clinical Trial”
- [Artículo traducido] Efectos adversos graves por errores de formulación de minoxidil oral a bajas dosis para el tratamiento de la alopecia
- Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations
- Development and validation of a procedure for the determination of minoxidil in hair-regrowth formulations using two variants of capillary zone electrophoresis
- IMPROVED SKIN PENETRATION AND DEPOSITION OF NAFTIFINE FROM TRANSETHOSOMES AND TRANSETHOSOMAL GEL FORMULATIONS
- The evolution of three generations of platelet concentrates products: a leap from classical formulations to the era of extracellular vesicles
- RP HPLC method for the determination of finasteride andtamsulosin in bulk and pharmaceutical formulations
- Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS—A prospective study
- Development and Validation of Spectrophotometric Method for Determination of Finasteride in Pharmaceutical Formulation Using 1,2-Naphthoquine-4-sulfonate (NQS)
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
- HAIR TONIC OF BROCCOLI (BRASSICA OLERACEA VAR. ITALICA) EXTRACT: FORMULATION, PHYSICAL CHARACTERISTIC, STABILITY AND HAIR GROWTH ACTIVITY TEST
- Second derivative spectrophotometric method for simultaneous determination of tamsulosin and finasteride in pharmaceutical formulations
- Targeted Nanoparticle Delivery for Vascular Regeneration and Ischemia-Reperfusion Injury through Multi-Objective Formulation Optimization
- Therapeutic Potential of Ziziphus Mauritiana and Black Seed Oil in Herbal Hair Care Formulation
- Potential of Semecarpus anacardium in Herbal Cosmeceuticals: From Traditional Hair Care to Modern Formulations
- 3D bioprinted melanoma constructs reveal delivery-dependent efficacy of phytochemical-gold nanoparticle formulations
- Real‐World Clinical Outcomes With a 1% SeleniumSulfide/1% Salicylic Acid Shampoo Formulation for Seborrheic Dermatitis and Dandruff: A Multicenter Observational Study
- Exploring murE protein inhibitors of Tropheryma whipplei through pharmacoinformatic approaches incorporating solubility-enhancing formulation insights
- Colour cosmetics: Extraction and application of plant-based pigments in the shampoo formulation
- Synergistic Phytochemical and Pharmacological Actions of Hair RiseTM Microemulsion: A Novel Herbal Formulation for Androgenetic Alopecia and Hair Growth Stimulation
- Approaches for estimating the clinical starting dose of new dosage forms: An example of a long-acting injectable formulation of finasteride
- RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF FINASTERIDE AND TAMSULOSIN IN TABLET FORMULATIONS
- RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF FINASTERIDE AND TAMSULOSIN IN TABLET FORMULATIONS
- A Nationwide Outbreak of Alopecia Associated With the Use of a Hair-Relaxing Formulation
- A 6-month prospective study on efficacy safety and QOL profiles of extended-release formulation of valproate in patients with epilepsy
- Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo<sup>®</sup> hair growth factor formulation: A phase‐IV, open‐label, single‐arm multi‐ethnicity clinical trial